Uncategorized
Valeant reports growth in fourth quarter, fiscal year 2014 revenues
Valeant Pharmaceuticals totaled $8.3 billion in revenue in the fiscal year 2014, a 43% increase from 2013, according to a press release.In the fourth quarter 2014, total revenue was $2.3 billion, a 10% increase from the fourth quarter 2013.